Related Experiment Video
Updated: Dec 24, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage
Eduardo A Sagredo1, Alfredo I Sagredo1, Alejandro Blanco2
1Center of Excellence in Precision Medicine, Pfizer Chile, Obispo Arturo Espinoza Campos 2526, CP 7810305 Santiago, Chile; Centro de Investigación y Tratamiento del Cáncer, Facultad de Medicina, Universidad de Chile, Independencia 1027, Santiago, Chile.
Abstract:
RNA editing has emerged as a novel mechanism in cancer progression. The double stranded RNA-specific adenosine deaminase (ADAR) modifies the expression of an important proportion of genes involved in cell cycle control, DNA damage response (DDR) and transcriptional processing, suggesting an important role of ADAR in transcriptome regulation. Despite the phenotypic implications of ADAR deregulation in several cancer models, the role of ADAR on DDR and proliferation in breast cancer has not been fully addressed. Here, we show that ADAR expression correlates significantly with clinical outcomes and DDR, cell cycle and proliferation mRNAs of previously reported edited transcripts in breast cancer patients. ADAR's knock-down in a breast cancer cell line produces stability changes of mRNAs involved in DDR and DNA replication. Breast cancer cells with reduced levels of ADAR show a decreased viability and an increase in apoptosis, displaying a significant decrease of their DDR activation, compared to control cells. These results suggest that ADAR plays an important role in breast cancer progression through the regulation of mRNA stability and expression of those genes involved in proliferation and DDR impacting the viability of breast cancer cells.
Insights
The double stranded RNA-specific adenosine deaminase (ADAR) enzyme impacts breast cancer progression by regulating genes involved in DNA damage response and cell proliferation. Reduced ADAR levels decrease cancer cell viability and increase apoptosis.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- RNA editing is a key mechanism in cancer progression.
- ADAR enzymes regulate genes crucial for cell cycle, DNA damage response (DDR), and transcription.
- The specific role of ADAR in breast cancer DDR and proliferation remains under-investigated.
Purpose of the Study:
- To investigate the role of ADAR in breast cancer progression.
- To determine the correlation between ADAR expression, clinical outcomes, and key gene pathways in breast cancer patients.
- To elucidate ADAR's impact on mRNA stability, cell viability, and DDR activation in breast cancer cells.
Main Methods:
- Correlation analysis of ADAR expression with clinical data and mRNA levels of edited transcripts.
- ADAR knockdown experiments in breast cancer cell lines.
- Assessment of mRNA stability, cell viability, apoptosis, and DDR activation.
Main Results:
- ADAR expression significantly correlates with clinical outcomes and mRNA levels of DDR, cell cycle, and proliferation genes in breast cancer.
- ADAR knockdown alters mRNA stability of DDR and DNA replication genes.
- Reduced ADAR levels in breast cancer cells lead to decreased viability, increased apoptosis, and diminished DDR activation.
Conclusions:
- ADAR plays a significant role in breast cancer progression.
- ADAR regulates mRNA stability and expression of proliferation and DDR genes.
- ADAR impacts breast cancer cell viability through modulation of DDR pathways.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

